SRRA's logo.
Ticker Symbol: SRRA

Sierra Oncology Inc

$21.90 - 20-12-2024 4 p.m. ET

Exchange: NASDAQ Country: Canada Currency: USD Asset Type: Common Stock CIK:0001290149

Company Profile

Sierra Oncology is a late-stage biopharmaceutical company on a quest to deliver targeted therapies that treat rare forms of cancer. Sierra Oncology harnesses its deep scientific expertise to identify compounds that target the root cause of disease to advance targeted therapies with assets on the leading edge of cancer biology. Its team takes an evidence-based approach to understand the limitations of current treatments and explore new ways to change the cancer treatment paradigm. Sierra Oncology is transforming promise into patient impact.

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 2150 ? 885 West Georgia Street
CEO: Stephen Dilly
Tags:
  • Health Technology
  • Biotechnology
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

Pricing

Last Updated: December 31, 1969 07:00 PM EST
Previous Close: -
Change: $0.02 ( 0.04%)
Days Range: $54.99 - $54.99
Beta: -
52wk. High: -
52wk. Low: -
Ytd. Change 0.04%
50 Day Moving Average: -
200 Day Moving Average: -
Shares Outstanding: 24419349

Valuation

Market Cap: 134.3B
PE Ratio: -
EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A